Finally, when we restricted the main analyses in subgroup with no maternal use of glucocorticoids, there was a similar trend of increased CP risk in female offspring born at term who were exposed to maternal use of β2AAs, although it did not reach statistical significance ( S4 Table ).
← all excerpts
Risk of childhood cerebral palsy following prenatal exposure to ß2-adrenergic receptor agonist: A nationwide cohort study.
1
—
—